found that both mRNA and protein levels of NLRP3 are markedly down-regulated in hepatic parenchymal cells derived from liver cancer, suggesting an antitumorigenic role of NLRP3 hepatocellular carcinoma (67). Here, NLRP3 is linked to hepatocellular carcinoma.